Related by context. Frequent words. (Click for all words.) 68 DIARY Federal Reserve 63 Patient Outcomes 63 Improves Survival 63 Cholesterol Drug 62 Heart Failure Patients 62 Acute Myocardial Infarction 61 Cardiovascular Risk 61 Venous Thromboembolism 61 Ischemic 61 Contraindications 60 Randomized controlled 60 Renal Cell Carcinoma 60 Gastric Cancer 60 Help Predict 60 Inhaled Insulin 59 Annoucement 59 Pioglitazone 59 Dyslipidemia 59 Industry Announcements 59 Pivotal Phase III 59 Phase III Clinical Trial 59 Acute Coronary Syndrome 59 Pivotal Phase 59 Patients Undergoing 59 Phase III Trial 59 Postmenopausal Women 59 Pivotal Trial 59 Gene Mutation 58 Hepatocellular Carcinoma 58 Initiates Phase II 58 Etanercept 58 Chronic Heart Failure 58 Prostate Cancer Prevention 58 Completes Enrollment 58 Clinical Trial Results 58 Meta Analysis 58 Antihypertensive 58 Surgical Treatment 58 Gender Differences 58 Benign Prostatic Hyperplasia 57 cardiovascular ischemic 57 Acute Ischemic Stroke 57 Cognitive Function 57 Autoimmune Disease 57 Diabetic Patients 57 Cervical Cancer Vaccine 57 Drug Candidate 56 Gum Disease 56 Novel Approach 56 Insulin Resistance 56 Bioequivalence 56 Pediatric Patients 56 Low Dose 56 J Am Coll 56 Atopic Dermatitis 56 Anticoagulation 56 Systematic Review 56 Urinary Incontinence 56 Racial Disparities 56 Diabetic Neuropathy 56 Initiate Phase 55 Blood Vessels 55 ONTARGET 55 Pulmonary Arterial Hypertension 55 RE LY 55 HALTS 55 II Clinical Trial 55 Pharmacokinetic 55 Prostate Cancer Treatment 55 Targeted Therapy 55 Solid Tumors 55 Cholesterol Levels 54 Arch Neurol 54 AVANDIA 54 Patient Recruitment 54 Phase IIIb 54 Stroke Risk 54 Golimumab 54 Brain Cells 54 Allergic Rhinitis 54 Chronic Lymphocytic Leukemia 54 Cost Effectiveness 54 Antipsychotic 54 Breast Cancer Risk 54 Enoxaparin 54 Vitamin D Deficiency 53 Immune Cells 53 Quitting Smoking 53 Percutaneous Coronary Intervention 53 Metastases 53 Psychiatric Disorders 53 Dasatinib 53 Overactive Bladder 53 EVEREST II 53 Elderly Patients 53 heparin induced thrombocytopenia 53 Epidermal Growth Factor Receptor 53 Receives Orphan Drug Designation 53 Preclinical Data 53 Well Tolerated 53 Adrenal